The global lip injection market is expected to reach US$7.8 billion by 2034, up from US$3.8 billion in 2024. The market is projected to expand at a compound annual growth rate (CAGR) of 7.4 per cent between 2025 and 2034.
Growing demand for minimally invasive cosmetic procedures continues to fuel market growth. Consumers increasingly prefer treatments that deliver quick results with little recovery time. Rising awareness of facial aesthetics and stronger social media influence also encourage more people to consider lip enhancement procedures.
North America remains the leading market
North America led the global market in 2024. The region accounted for 42.2 per cent of total revenue, generating approximately US$1.6 billion. Advanced healthcare infrastructure, high consumer awareness, and widespread access to qualified practitioners supported regional growth.
Industry data highlights the increasing acceptance of lip injections. The American Society of Plastic Surgeons reported nearly 1.45 million lip augmentation procedures using injectable materials in 2024. The figure represented a slight increase from the previous year.
Hyaluronic acid fillers dominate demand
Hyaluronic acid fillers remain the most popular product category. They accounted for more than half of the market because they deliver natural-looking results and offer a strong safety profile. Physicians also prefer these fillers because they can reverse the treatment if necessary.
The American Society of Plastic Surgeons reported more than 5.3 million hyaluronic acid filler procedures in 2024. Non-hyaluronic acid fillers accounted for fewer than one million procedures during the same period. These figures demonstrate the strong consumer preference for hyaluronic acid-based products.
Temporary lip injections continue to dominate the market. They represented 72.1 per cent of total demand because they offer flexibility and lower long-term commitment. Cosmetic enhancement remained the leading application, contributing 62.5 per cent of market revenue.
Specialty and dermatology clinics emerged as the largest end-user segment. They captured 40.3 per cent of total market revenue. Drug pharmacies and retail channels also maintained a strong position by accounting for 51.1 per cent of distribution.
Innovation and practitioner availability support growth
Professional organisations continue to report rising demand for injectable treatments. The American Academy of Facial Plastic and Reconstructive Surgery stated that about 90 per cent of facial plastic surgeons routinely perform dermal filler and neurotoxin procedures. Non-surgical treatments now account for nearly 80 per cent of facial aesthetic procedures performed by its members.
Manufacturers continue investing in product innovation. Companies are developing fillers with improved flexibility, longer-lasting effects, and greater patient comfort. Strategic acquisitions also support technological advances. Prollenium Medical Technologies strengthened its portfolio by acquiring SoftFil in 2022, expanding innovation in injection devices and filler delivery systems.
Asia Pacific offers strong growth potential
Asia Pacific is expected to record the fastest market growth during the forecast period. Rising disposable incomes, expanding medical aesthetics clinics, and growing beauty awareness continue to drive demand across China, Japan, South Korea, and India.
Industry experts also expect increasing adoption among male consumers to create new growth opportunities. Many younger adults now seek preventive cosmetic treatments rather than corrective procedures. This trend continues to expand the customer base for injectable facial enhancements.
Growing consumer spending, expanding access to qualified practitioners, and continued innovation are expected to sustain long-term market growth. Increasing demand for safe, personalised, and minimally invasive aesthetic treatments is likely to support the lip injection market throughout the forecast period.